MG1 HPV
Alternative Names: MG1-HPVLatest Information Update: 28 Jul 2021
At a glance
- Originator Turnstone Biologics
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jul 2021 No recent reports of development identified for phase-I development in Cancer(Combination therapy, Metastatic disease, Recurrent) in Canada (IM, Injection)
- 28 Jul 2021 No recent reports of development identified for phase-I development in Cancer(Combination therapy, Metastatic disease, Recurrent) in USA (IM, Injection)
- 05 Mar 2021 Turnstone Biologics discontinues phase I trial due to preliminary data in Cancer in Canada and USA (NCT03618953)